Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jimenez

Showing results (341-350 of 456) with videos related to

Pageof 46
Sort By:
Biorxiv : the Preprint Server for Biology|February 8, 2024
Chikungunya Virus Release is Reduced by TIM-1 Receptors Through Binding of Envelope PhosphatidylserineJudith M Reyes Ballista, Ashley J Hoover, Joseph T Noble, et al.
Molecular Oncology|November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancerFranziska Böttger, Teodora Radonic, Idris Bahce, et al.
International Journal of Molecular Sciences|August 7, 2021
Effects of Cancer Presence and Therapy on the Platelet ProteomeMaudy Walraven, Siamack Sabrkhany, Jaco C Knol, et al.
Journal of Virology|July 15, 2024
Chikungunya virus release is reduced by TIM-1 receptors through binding of envelope phosphatidylserineJudith M Reyes Ballista, Ashley J Hoover, Joseph T Noble, et al.
BMC Cancer|September 17, 2017
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter studyBernies van der Hiel, John B A G Haanen, Marcel P M Stokkel, et al.
Molecular & Cellular Proteomics : MCP|July 27, 2011
Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic targetW J Van Houdt, B L Emmink, T V Pham, et al.
Gut|September 6, 2011
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progressionMeike de Wit, Connie R Jimenez, Beatriz Carvalho, et al.
Journal of Internal Medicine|October 18, 2019
Fructose metabolism as a common evolutionary pathway of survival associated with climate change, food shortage and droughtsR J Johnson, P Stenvinkel, P Andrews, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2025
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapyElisabeth J M Huijbers, Judy R van Beijnum, Karlijn van Loon, et al.
Nature Communications|May 23, 2022
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapyJudy R van Beijnum, Elisabeth J M Huijbers, Karlijn van Loon, et al.
Pageof 46

Showing results (341-350 of 456) with videos related to

Sort By:
Pageof 46
Biorxiv : the Preprint Server for Biology|February 8, 2024
Chikungunya Virus Release is Reduced by TIM-1 Receptors Through Binding of Envelope PhosphatidylserineJudith M Reyes Ballista, Ashley J Hoover, Joseph T Noble, et al.
Molecular Oncology|November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancerFranziska Böttger, Teodora Radonic, Idris Bahce, et al.
International Journal of Molecular Sciences|August 7, 2021
Effects of Cancer Presence and Therapy on the Platelet ProteomeMaudy Walraven, Siamack Sabrkhany, Jaco C Knol, et al.
Journal of Virology|July 15, 2024
Chikungunya virus release is reduced by TIM-1 receptors through binding of envelope phosphatidylserineJudith M Reyes Ballista, Ashley J Hoover, Joseph T Noble, et al.
BMC Cancer|September 17, 2017
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter studyBernies van der Hiel, John B A G Haanen, Marcel P M Stokkel, et al.
Molecular & Cellular Proteomics : MCP|July 27, 2011
Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic targetW J Van Houdt, B L Emmink, T V Pham, et al.
Gut|September 6, 2011
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progressionMeike de Wit, Connie R Jimenez, Beatriz Carvalho, et al.
Journal of Internal Medicine|October 18, 2019
Fructose metabolism as a common evolutionary pathway of survival associated with climate change, food shortage and droughtsR J Johnson, P Stenvinkel, P Andrews, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2025
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapyElisabeth J M Huijbers, Judy R van Beijnum, Karlijn van Loon, et al.
Nature Communications|May 23, 2022
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapyJudy R van Beijnum, Elisabeth J M Huijbers, Karlijn van Loon, et al.
Pageof 46